APP and Alzheimer disease: Multiple preclinical and clinical studies found region-specific TSPO-PET increases in patients with AD [13] and models of AD neuropathology [14]; moreover, increased TSPO could be detected in microglial proteome of AD mouse models (APPPS1 and APP-KI) [15].